Europe Aquaculture Vaccines Market to grow at 6.4% CAGR from 2021 to 2027: Graphical Research European Aquaculture Vaccines Market size is poised to exceed USD 170.3 million by 2027, according to a latest forecast report by Graphical Research. Surging prevalence of bacterial and viral infections is the major driving factor of the market revenue. Infectious disease is one of the most vital limiting factors in aquaculture. For most warmwater aquaculture facilities, disease prevention consists of good husbandry techniques. When disease outbreak occurs, diagnostics are conducted to determine the actual cause and then the fish are given oral treatment that is an immersion or in rare cases injection treatment. This leads to huge losses both in terms of yield and economic. Thus, to limit the economic losses, the use of vaccines is increasing across the region. Development and launch of new aquaculture vaccines will drive the aquaculture vaccines market. Bactrians are vaccines comprised of killed forms of pathogenic bacteria. Live attenuated vaccines consist of live micro-organisms that have been grown in culture. There are different kind of vaccine that are being developed and launched for better aquaculture farming resulting into better production of aquaculture. Also, companies are investing in R&D programs for innovating vaccines.
Live aquaculture vaccines market size was more than USD 17.7 million in 2020. Live vaccines are quite effective and retain attributes of natural infection. In commercial application, live vaccines have greater potential to be administered via immersion or oral routes. Live vaccine mode of administration is more dynamic compared to inactivated vaccines that must utilize adjuvants. Immersion vaccines segment is predicted to register a growth of over 6.9% from 2021 to 2027. Immersion vaccines are used for variety of aquaculture fish for preventing infectious diseases caused by viruses and bacteria. During immersion vaccination, the antigens are taken up by the gills, gut or skin and processed by the immune system where the response results in protection of fish. Administration of vaccines also depends on the size of fish and in many cases, immersion vaccination is mostly preferred as compared to injection vaccination to achieve optimum protection. Viral infection segment revenue is expected to reach USD 27.4 million by 2027. In aquaculture both wild aquatic and farmed animals in the same water column experience the same viral challenges. Expanding global trade and burgeoning international aquaculture expansion and their products have been accomplished by long distance geographical redistribution of aquatic species and their viruses.
1|Page